Back to Trades
Carter Robert Ross
Chief Financial OfficerCIK 0002039341
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, Carter Robert Ross, Chief Financial Officer, has disclosed $70.9K in transactions — all concentrated in Starling Oncology, Inc. (STLN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $879 in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Nov 19 | STLN Starling Oncology, Inc. | Carter Robert Ross | Chief Financial Officer | Other | $469 |
| May 22 | TOI Oncology Institute, Inc. | Carter Robert Ross | Chief Financial Officer | Other | $7.2K |
| Apr 1 | TOI Oncology Institute, Inc. | Carter Robert Ross | Chief Financial Officer | Grant | $62.4K |
| Jan 5 | TOI Oncology Institute, Inc. | Carter Robert Ross | Chief Financial Officer | Sell | $879 |
| Nov 19 | TOI Oncology Institute, Inc. | Carter Robert Ross | Chief Financial Officer | Grant | $0 |
5 filings